<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2127">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on September 19, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01921517</url>
  </required_header>
  <id_info>
    <org_study_id>3408455</org_study_id>
    <nct_id>NCT01921517</nct_id>
  </id_info>
  <brief_title>Micromechanical Modeling Using Low Magnitude Mechanical Stimulation</brief_title>
  <acronym>LMMS</acronym>
  <official_title>Osteoporosis Treatment Response Assessed by Micromechanical Modeling of MRI Data</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Children's Hospital of Philadelphia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The response to a daily 10 minute session of low-magnitude mechanical stimulation (LMMS) on&#xD;
      bone in 100 postmenopausal women ages 45-65 years will be evaluated at baseline and 12 months&#xD;
      using high-resolution magnetic resonance (MR) imaging. Subjects will be assigned to an active&#xD;
      platform that produces vibrations or to a placebo platform that produces no vibrations.&#xD;
&#xD;
      The investigators propose to evaluate the hypothesis that LMMS applied to postmenopausal&#xD;
      women ages 45-65 improves the mechanical integrity of bone while lowering marrow adiposity.&#xD;
&#xD;
        1. The investigators will optimize an integrated imaging protocol for high-resolution&#xD;
           structural MR imaging of the distal tibia and spectroscopic imaging-based quantification&#xD;
           of bone marrow composition in the lumbar vertebrae.&#xD;
&#xD;
        2. The investigators will further develop and validate micro-finite-element (FE) analysis&#xD;
           for quantitative assessment of trabecular and cortical bone stiffness and failure load&#xD;
           from high-resolution MR images of the distal tibia.&#xD;
&#xD;
        3. The investigators will apply the methodology of Aims 1 and 2 (above) in a&#xD;
           double-blinded, randomized, placebo-controlled study to a cohort of 100 healthy&#xD;
           postmenopausal women in the age range of 45-65 years, studied at baseline and 12 months&#xD;
           after having been subjected to 10 minutes daily of either 30 Hz/0.3g stimulation or&#xD;
           placebo treatment, monitored rigorously via electronic feedback.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Weightbearing exercise has an osteogenic effect by reducing bone resorption and enhancing&#xD;
      bone formation. During the past several years a number of articles have appeared&#xD;
      demonstrating that low-magnitude mechanical stimulation (LMMS) is osteogenic in animals and&#xD;
      also in humans. Preclinical studies have also demonstrated an effect of decrease in&#xD;
      adiposity. The mechanobiology underlying these phenomena is beginning to emerge in terms of&#xD;
      expression of genes stimulated by the action of the vibrations to which osteocytes and&#xD;
      adipocytes are subjected.&#xD;
&#xD;
      If successful, LMMS treatment, a non-pharmacologic intervention, could prevent bone loss and&#xD;
      potentially stimulate bone formation and decreased adipocyte production resulting in&#xD;
      increased bone strength and reduced fracture susceptibility in subjects at risk of developing&#xD;
      osteoporosis. The proposed project focuses directly on measures of strength by evaluating the&#xD;
      therapeutic response in terms of magnetic resonance (MR) image-based micro finite-element&#xD;
      (FE) assessment of bone stiffness and failure strength, along with quantifying&#xD;
      treatment-induced changes in marrow adiposity, as part of a single, integrated examination,&#xD;
      conducted at baseline and 12 months of treatment in a double-blinded, randomized,&#xD;
      placebo-controlled study of early postmenopausal women.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Actual">June 20, 2019</completion_date>
  <primary_completion_date type="Actual">February 28, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Distal Tibia Bone Quality</measure>
    <time_frame>Baseline to 12 months</time_frame>
    <description>Distal tibial bone quality is measured through MRI by calculating the ratio between bone volume to total volume. A lower value would indicate osteoporotic (weaker) bone; a higher value would indicate healthy (normal) bone.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">117</enrollment>
  <condition>Bone Alteration</condition>
  <arm_group>
    <arm_group_label>Low Magnitude Mechanical Stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10 minutes daily of 30 Hz/0.3g stimulation using a vibrating platform.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham Low Magnitude Mechanical Stimulation</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>10 minutes daily of placebo treatment using a sham vibrating platform.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Low Magnitude Mechanical Stimulation</intervention_name>
    <description>Mechanical stimulation for 10 minutes daily for 12 months at a frequency of 30 Hz and acceleration of 0.3 g.</description>
    <arm_group_label>Low Magnitude Mechanical Stimulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham Low Magnitude Mechanical Stimulation</intervention_name>
    <description>Mechanical stimulation for 10 minutes daily for 12 months using a sham device.</description>
    <arm_group_label>Sham Low Magnitude Mechanical Stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Females, ages 45-65 years and post menopausal, as defined by a history of amenorrhea&#xD;
             for a minimum of 24 months and a serum FSH (follicle-stimulating hormone)&#xD;
             concentration of 25 mIU/mL (milli-International unit per milliliter) and negative&#xD;
             pregnancy test.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Current or prior use of medications known to affect bone (e.g. bisphosphonates,&#xD;
             calcitonin, selective estrogen receptor modulators, denosumab, diphenylhydantoin,&#xD;
             recent systemic glucocorticoid use), bone mineral density T score of less than -2.5&#xD;
             and greater than +2, Vitamin D level less then 12 ng/ml, BMI (body mass index) of&#xD;
             greater than 32, current alcohol or drug abuse: more than 3 alcoholic beverages per&#xD;
             day or current abuse of illicit drugs or prescription medication, uncontrolled or&#xD;
             untreated cardiac or pulmonary disease liver disease: history of hepatitis or ALT&#xD;
             (alanine aminotransferase) or AST (aspartate aminotransferase) greater than 2x ULN&#xD;
             (upper limit of normal), renal disease: history of renal disease or serum creatinine&#xD;
             greater than 2x ULN diabetes, pacemaker or metallic implants considered a&#xD;
             contraindication to MR scanning.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Felix W Wehrli, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>August 8, 2013</study_first_submitted>
  <study_first_submitted_qc>August 8, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 13, 2013</study_first_posted>
  <results_first_submitted>October 21, 2019</results_first_submitted>
  <results_first_submitted_qc>November 13, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">November 15, 2019</results_first_posted>
  <last_update_submitted>November 13, 2019</last_update_submitted>
  <last_update_submitted_qc>November 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pennsylvania</investigator_affiliation>
    <investigator_full_name>Felix Wehrli</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Biomechanics</keyword>
  <keyword>Osteogenesis</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol, Statistical Analysis Plan, and Informed Consent Form</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>October 24, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/17/NCT01921517/Prot_SAP_ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Not all subjects enrolled (consented at screening visit) were randomized (randomized to intervention)</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Low Magnitude Mechanical Stimulation</title>
          <description>10 minutes daily of 30 Hz/0.3g stimulation using a vibrating platform.&#xD;
Low Magnitude Mechanical Stimulation: Mechanical stimulation for 10 minutes daily for 12 months at a frequency of 30 Hz and acceleration of 0.3 g.</description>
        </group>
        <group group_id="P2">
          <title>Sham Low Magnitude Mechanical Stimulation</title>
          <description>10 minutes daily of placebo treatment using a sham vibrating platform.&#xD;
Sham Low Magnitude Mechanical Stimulation: Mechanical stimulation for 10 minutes daily for 12 months using a sham device.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="42"/>
                <participants group_id="P2" count="38"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
                <participants group_id="P2" count="29"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Newly diagnosed health concern</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Subject missed final imaging</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Low Magnitude Mechanical Stimulation</title>
          <description>10 minutes daily of 30 Hz/0.3g stimulation using a vibrating platform.&#xD;
Low Magnitude Mechanical Stimulation: Mechanical stimulation for 10 minutes daily for 12 months at a frequency of 30 Hz and acceleration of 0.3 g.</description>
        </group>
        <group group_id="B2">
          <title>Sham Low Magnitude Mechanical Stimulation</title>
          <description>10 minutes daily of placebo treatment using a sham vibrating platform.&#xD;
Sham Low Magnitude Mechanical Stimulation: Mechanical stimulation for 10 minutes daily for 12 months using a sham device.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="42"/>
            <count group_id="B2" value="38"/>
            <count group_id="B3" value="80"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="80"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="80"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="53"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Distal Tibia Bone Quality</title>
        <description>Distal tibial bone quality is measured through MRI by calculating the ratio between bone volume to total volume. A lower value would indicate osteoporotic (weaker) bone; a higher value would indicate healthy (normal) bone.</description>
        <time_frame>Baseline to 12 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Low Magnitude Mechanical Stimulation</title>
            <description>10 minutes daily of 30 Hz/0.3g stimulation using a vibrating platform.&#xD;
Low Magnitude Mechanical Stimulation: Mechanical stimulation for 10 minutes daily for 12 months at a frequency of 30 Hz and acceleration of 0.3 g.</description>
          </group>
          <group group_id="O2">
            <title>Sham Low Magnitude Mechanical Stimulation</title>
            <description>10 minutes daily of placebo treatment using a sham vibrating platform.&#xD;
Sham Low Magnitude Mechanical Stimulation: Mechanical stimulation for 10 minutes daily for 12 months using a sham device.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Distal Tibia Bone Quality</title>
          <description>Distal tibial bone quality is measured through MRI by calculating the ratio between bone volume to total volume. A lower value would indicate osteoporotic (weaker) bone; a higher value would indicate healthy (normal) bone.</description>
          <units>percentage of change</units>
          <param>Mean</param>
          <dispersion>80% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.121" lower_limit="-0.35" upper_limit="2.29"/>
                    <measurement group_id="O2" value="-2.141" lower_limit="-4.53" upper_limit="0.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0481</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event data was collected over five years.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Low Magnitude Mechanical Stimulation</title>
          <description>10 minutes daily of 30 Hz/0.3g stimulation using a vibrating platform.&#xD;
Low Magnitude Mechanical Stimulation: Mechanical stimulation for 10 minutes daily for 12 months at a frequency of 30 Hz and acceleration of 0.3 g.</description>
        </group>
        <group group_id="E2">
          <title>Sham Low Magnitude Mechanical Stimulation</title>
          <description>10 minutes daily of placebo treatment using a sham vibrating platform.&#xD;
Sham Low Magnitude Mechanical Stimulation: Mechanical stimulation for 10 minutes daily for 12 months using a sham device.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="38"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="42"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Diarrhea</sub_title>
                <description>Mild</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <description>Mild</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="42"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="38"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <description>Mild</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="42"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="38"/>
              </event>
              <event>
                <sub_title>Heavy Feeling in Bones</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Bone Pain</sub_title>
                <description>Mild</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Itching/Redness</sub_title>
                <description>Mild</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="42"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="38"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <description>Mild</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Felix W. Wehrli, Principal Investigator</name_or_title>
      <organization>University of Pennsylvania Perelman School of Medicine</organization>
      <phone>215-662-7951</phone>
      <email>felix.wehrli@pennmedicine.upenn.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

